enocitabine has been researched along with ancitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eizuru, Y; Kumura, K; Minamishima, Y; Nakamura, K | 1 |
| Nakamura, T; Ueda, T | 1 |
| Kimura, K; Takenaka, T | 1 |
1 review(s) available for enocitabine and ancitabine
| Article | Year |
|---|---|
[Chemotherapy of the malignancies from the viewpoint of pharmacology and biochemistry of cytosine arabinoside (ara-C) and its derivatives].
Topics: Ancitabine; Cytarabine; Humans; Kinetics; Leukemia | 1982 |
2 other study(ies) available for enocitabine and ancitabine
| Article | Year |
|---|---|
Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus.
Topics: Ancitabine; Antiviral Agents; Cells, Cultured; Cytarabine; Cytomegalovirus; DNA Replication; DNA, Viral; Fibroblasts; Humans; Nucleotides; Virus Replication | 1990 |
Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC.
Topics: Ancitabine; Animals; Antineoplastic Agents; Cytarabine; Kinetics; Mice; Structure-Activity Relationship | 1984 |